Multicentre evaluation of the Elecsys® hepatitis B surface antigen II assay for detection of HBsAg in comparison with other commercially available assays

Medical Microbiology and Immunology

Volumn 198, Issue 4, 2009, Pages 263-269

  Jia, Ji Dong ^a   Hong, Ma ^a   Wei, Lai ^b   Zhang, Xin Xin ^c   Mao, Yuan Li ^d   Wang, Lan Lan ^e   Gao, Zhi Liang ^f   Hou, Jin Lin ^g   Zhang, Jun ^h  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^c SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^d BEIJING 302 HOSPITAL   (China)

^e SICHUAN UNIVERSITY   (China)

^f SUN YAT SEN UNIVERSITY   (China)

^g SOUTHERN MEDICAL UNIVERSITY   (China)

^h FUDAN UNIVERSITY   (China)

Author keywords

HBV mutants; Hepatitis B surface antigen (HBsAg); Hepatitis B virus; Immunoassay

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; RECOMBINANT ANTIGEN;

ANALYZER; ANTIGEN DETECTION; ARTICLE; AUTOANALYSIS; CHINA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS B VIRUS; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; MICROTITER PLATE ASSAY; MULTICENTER STUDY; PRIORITY JOURNAL; SEROCONVERSION; VIRUS DETECTION; VIRUS GENE; VIRUS MUTANT;

CHINA; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HUMANS; IMMUNOASSAY; REAGENT KITS, DIAGNOSTIC; SENSITIVITY AND SPECIFICITY;

EID: 70350576589     PISSN: 03008584     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00430-009-0127-4     Document Type: Article

References (22)

1. D Ganem AM Prince 2004 Hepatitis B virus infection-natural history and clinical consequences N Engl J Med 350 1118 1129 10.1056/NEJMra031087 1:CAS:528:DC%2BD2cXitV2qurs%3D 15014185 (Pubitemid 38298992)
2. JH Hoofnagel AM DiBisciglie 1991 Serologic diagnosis of acute and chronic viral hepatitis Semin Liver Dis 11 73 83 10.1055/s-2008-1040426
3. G Frösner H Schomerus KH Wiedmann R Zachoval B Bayer U Bäcker, et al. 1982 Diagnostic significance of quantitative HBsAg determination in acute and chronic hepatitis B infection Eur J Clin Microbiol 1 52 58 10.1007/BF02014141 7173171
4. Centers for Disease Control, Prevention 1998 Recommendations of the immunisation practices advisory committee: prevention of perinatal transmission of hepatitis B virus: prenatal screening of all pregnant women for hepatitis-B surface antigen MMWR 37 341 355
5. S Nick H Scheiblauer 2007 Sensitivities of CE-marked HIV, HCV and HBsAg assays J Medical Virol 79 S59 S64 10.1002/jmv.20965 1:CAS:528:DC%2BD2sXhtFyisLrK (Pubitemid 47479877)
6. A Katsoulidou Z Moschidis V Sypsa M Chini GV Papatheodoridis NC Tassopoulos, et al. 2007 Analytical and clinical sensitivity of the Procelix Ultrio HIV-1/HCVHBV assay in samples with a low viral load Vox Sanguinis 92 8 14 10.1111/j.1423-0410.2006.00857.x 1:CAS:528:DC%2BD2sXivVGruro%3D 17181585 (Pubitemid 44950344)
7. European Community (1998) EC directive 98/79/EC. Official Journal of the European Communities. L331/1
8. B Weber 2005 Recent developments in the diagnosis and monitoring of HBV infection and role of the genetic variability of the S gene Expert Rev Mol Diagn 5 75 91 10.1586/14737159.5.1.75 1:CAS:528:DC%2BD2MXht1yqsrk%3D 15723594 (Pubitemid 40138770)
9. DR Dufour 2006 Hepatitis B surface antigen (HBsAg) assay-are they good enough for their current uses? Clin Chem 52 1457 1459 10.1373/clinchem.2006. 072504 1:CAS:528:DC%2BD28XnvFahtrs%3D 16873296 (Pubitemid 44148307)
10. W Gerlich 2004 Diagnostic problems caused by HBsAg mutants-a consensus report of an expert meeting Intervirology 47 310 313 10.1159/000080873 1:STN:280:DC%2BD2cnhsVyltg%3D%3D 15593449 (Pubitemid 39541276)
11. S Seddigh-Tonekaboni JA Waters S Jeffers, et al. 2000 Effect of variation in the common 'a' determinant on the antigenicity of hepatitis B surface antigen J Med Virol 60 113 121 10.1002/(SICI)1096-9071(200002)60:2<113::AID- JMV2>3.0.CO;2-0 1:CAS:528:DC%2BD3cXltlCrsQ%3D%3D 10596008 (Pubitemid 30036785)
12. B Weber 2005 Genetic variability of the S gene of hepatitis B virus: clinical and diagnostic impact J Clin Virol 32 102 112 10.1016/j.jcv.2004.10.008 1:CAS:528:DC%2BD2MXkvFChuw%3D%3D 15653412 (Pubitemid 40093960)
13. Roche Diagnostics Elecsys HBsAg II Package Insert (2007)
14. Abbott Diagnostics Architect Package Insert (2006)
15. Abbott Diagnostics AxSYM Package Insert (2008)
16. M Kane 1995 Global programme for control of hepatitis B infection Vaccine 13 Suppl 1 S47 S49 7571830
17. ASF Lok BJ McMahon 2007 Chronic hepatitis Hepatology 45 507 539 10.1002/hep.21513 1:CAS:528:DC%2BD2sXisVKns7o%3D 17256718 (Pubitemid 46374607)
18. C Pan J Jia C-J Chu J Hou K-Q Hu 2008 Epidemiology, presentation, and treatment of chronic HBV infection in mainland China, in Taiwan, and in Chinese Americans in the United States Curr Hepat B Rep 2 159 165
19. M Torbenson DL Thomas 2002 Occult hepatitis B Lancet Infect Dis 2 479 486 10.1016/S1473-3099(02)00345-6 12150847 (Pubitemid 34826853)
20. Y Fang X Teng WZ Xu D Li HW Zhao LJ Fu, et al. 2009 Molecular characterization and functional analysis of occult hepatitis B virus infection in Chinese patients infected with genotype C J Med Virol 81 826 835 10.1002/jmv.21463 1:CAS:528:DC%2BD1MXltVOhs7Y%3D 19319940
21. FB Hollinger 2007 Hepatitis B virus genetic diversity and its impact on diagnostic assays J Viral Hepat 14 Suppl 1 11 15 10.1111/j.1365-2893.2007.00910. x 17958637 (Pubitemid 47624107)
22. A Mühlbacher B Weber P Bürgisser A Eiras J Cabrera S Louisirirotchanakul, et al. 2008 Multicenter study of a new fully automated HBsAg screening assay with enhanced sensitivity for the detection of HBV mutants Med Microbiol Immunol 197 55 64 10.1007/s00430-007-0059-9 17899185 (Pubitemid 350161754)